invivo Mab anti-mouse CTLA-4 (CD152)

貨號:

BE0164

品牌:

Bioxcell

規格:

100mg

概述

別名:

InVivoMab anti-mouse CTLA-4 (CD152)

克隆類(lèi)型:

Monoclonal Antibodies

詳述

抗體應用:

未定義

我們優(yōu)化的專(zhuān)利抗體制造方法確保超純抗體溶液不添加蛋白質(zhì)或化學(xué)物質(zhì)。使用SDS-PAGE對每個(gè)批次的純度進(jìn)行QC測試。

我們的InVivoMAb產(chǎn)品≤2EU/mg，InVivoPlus產(chǎn)品≤1EU/mg。如果需要低于1EU/mg的內毒素水平，請聯(lián)系我們的技術(shù)支持以獲取詳細信息。

inVivoMab抗體
我們的InVivoMab?抗體專(zhuān)為體內使用而配制。它們的純度超過(guò)95％，內毒素水平超低，并且不含防腐劑，穩定劑和載體蛋白。我們的許多InVivoMab?抗體也可用于體外應用，包括蛋白質(zhì)印跡，ELISA，流式細胞儀分析，免疫熒光，免疫組化和免疫沉淀。通過(guò)SDS-PAGE篩選所有InVivoMab?產(chǎn)品的純度和完整性，并保證每毫克少于2個(gè)內毒素單位。如果需要其他質(zhì)量控制措施，例如鼠類(lèi)病原體測試和結合驗證，請參閱我們的InVivoPlus?抗體。

貨號	名稱(chēng)	?	克隆	反應性	抗原	宿主	同型	免疫原
BE0164-100MG	InVivoMab anti-mouse CTLA-4 (CD152)	?	9D9	mouse	CTLA-4 (CD152)	mouse?	IgG2b	?
BE0164-1MG	InVivoMab anti-mouse CTLA-4 (CD152)	?	9D9	mouse	CTLA-4 (CD152)	mouse?	IgG2b	?
BE0164-5MG	InVivoMab anti-mouse CTLA-4 (CD152)	?	9D9	mouse	CTLA-4 (CD152)	mouse?	IgG2b	?
BE0164-25MG	InVivoMab anti-mouse CTLA-4 (CD152)	?	9D9	mouse	CTLA-4 (CD152)	mouse?	IgG2b	?
BE0164-50MG	InVivoMab anti-mouse CTLA-4 (CD152)	?	9D9	mouse	CTLA-4 (CD152)	mouse?	IgG2b	?
BE0165-100MG	InVivoMab anti-mouse Nonclassical MHC Class I molecule Qa-1b	?	4C2.4A7.5H11	mouse	Nonclassical MHC Class I molecule Qa-1b	mouse?	IgG1	Peptide corresponding to residues 161-179 of Qa-1^b
BE0165-1MG	InVivoMab anti-mouse Nonclassical MHC Class I molecule Qa-1b	?	4C2.4A7.5H11	mouse	Nonclassical MHC Class I molecule Qa-1b	mouse?	IgG1	Peptide corresponding to residues 161-179 of Qa-1b
BE0165-5MG	InVivoMab anti-mouse Nonclassical MHC Class I molecule Qa-1b	?	4C2.4A7.5H11	mouse	Nonclassical MHC Class I molecule Qa-1b	mouse?	IgG1	Peptide corresponding to residues 161-179 of Qa-1b
BE0165-25MG	InVivoMab anti-mouse Nonclassical MHC Class I molecule Qa-1b	?	4C2.4A7.5H11	mouse	Nonclassical MHC Class I molecule Qa-1b	mouse?	IgG1	Peptide corresponding to residues 161-179 of Qa-1b
BE0165-50MG	InVivoMab anti-mouse Nonclassical MHC Class I molecule Qa-1b	?	4C2.4A7.5H11	mouse	Nonclassical MHC Class I molecule Qa-1b	mouse?	IgG1	Peptide corresponding to residues 161-179 of Qa-1b
BE0166-100MG	InVivoMab anti-mouse Vβ4 TCR	?	KT4	mouse	Vβ4 TCR	rat?	IgG2b	KT4 B10.D2 mouse T cell clone I3
BE0166-1MG	InVivoMab anti-mouse Vβ4 TCR	?	KT4	mouse	Vβ4 TCR	rat?	IgG2b	KT4 B10.D2 mouse T cell clone I3
BE0166-5MG	InVivoMab anti-mouse Vβ4 TCR	?	KT4	mouse	Vβ4 TCR	rat?	IgG2b	KT4 B10.D2 mouse T cell clone I3
BE0166-25MG	InVivoMab anti-mouse Vβ4 TCR	?	KT4	mouse	Vβ4 TCR	rat?	IgG2b	KT4 B10.D2 mouse T cell clone I3
BE0166-50MG	InVivoMab anti-mouse Vβ4 TCR	?	KT4	mouse	Vβ4 TCR	rat?	IgG2b	KT4 B10.D2 mouse T cell clone I3
BE0167-100MG	InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)	?	14-4-4S (HB-32)	mouse/rat	MHC Class II (I-Ek/RT1-D)	mouse	IgG2a, κ	C3H mouse skin graft and spleen cells
BE0167-1MG	InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)	?	14-4-4S (HB-32)	mouse/rat	MHC Class II (I-Ek/RT1-D)	mouse	IgG2a, κ	C3H mouse skin graft and spleen cells
BE0167-5MG	InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)	?	14-4-4S (HB-32)	mouse/rat	MHC Class II (I-Ek/RT1-D)	mouse	IgG2a, κ	C3H mouse skin graft and spleen cells
BE0167-25MG	InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)	?	14-4-4S (HB-32)	mouse/rat	MHC Class II (I-Ek/RT1-D)	mouse	IgG2a, κ	C3H mouse skin graft and spleen cells
BE0167-50MG	InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)	?	14-4-4S (HB-32)	mouse/rat	MHC Class II (I-Ek/RT1-D)	mouse	IgG2a, κ	C3H mouse skin graft and spleen cells
BE0168-100MG	InVivoMab anti-mouse Vγ2 TCR	?	UC3-10A	mouse	Vγ2 TCR	Armenian hamster	IgG, κ	G8 mouse T cells
BE0168-1MG	InVivoMab anti-mouse Vγ2 TCR	?	UC3-10A	mouse	Vγ2 TCR	Armenian hamster	IgG, κ	G8 mouse T cells
BE0168-5MG	InVivoMab anti-mouse Vγ2 TCR	?	UC3-10A	mouse	Vγ2 TCR	Armenian hamster	IgG, κ	G8 mouse T cells
BE0168-25MG	InVivoMab anti-mouse Vγ2 TCR	?	UC3-10A	mouse	Vγ2 TCR	Armenian hamster	IgG, κ	G8 mouse T cells
BE0168-50MG	InVivoMab anti-mouse Vγ2 TCR	?	UC3-10A	mouse	Vγ2 TCR	Armenian hamster	IgG, κ	G8 mouse T cells
BE0169-100MG	InVivoMab anti-mouse 4-1BB (CD137)	?	LOB12.3	mouse	4-1BB (CD137)	rat?	IgG2a	Mouse CD137 human Fc fusion protein
BE0169-1MG	InVivoMab anti-mouse 4-1BB (CD137)	?	LOB12.3	mouse	4-1BB (CD137)	rat?	IgG2a	Mouse CD137 human Fc fusion protein
BE0169-5MG	InVivoMab anti-mouse 4-1BB (CD137)	?	LOB12.3	mouse	4-1BB (CD137)	rat?	IgG2a	Mouse CD137 human Fc fusion protein
BE0169-25MG	InVivoMab anti-mouse 4-1BB (CD137)	?	LOB12.3	mouse	4-1BB (CD137)	rat?	IgG2a	Mouse CD137 human Fc fusion protein
BE0169-50MG	InVivoMab anti-mouse 4-1BB (CD137)	?	LOB12.3	mouse	4-1BB (CD137)	rat?	IgG2a	Mouse CD137 human Fc fusion protein
BE0171-100MG	InVivoMab anti-mouse TIM-4	?	RMT4-53	mouse	TIM-4	rat	IgG2b, κ	Mouse TIM-4-Ig fusion protein
BE0171-1MG	InVivoMab anti-mouse TIM-4	?	RMT4-53	mouse	TIM-4	rat	IgG2b, κ	Mouse TIM-4-Ig fusion protein
BE0171-5MG	InVivoMab anti-mouse TIM-4	?	RMT4-53	mouse	TIM-4	rat	IgG2b, κ	Mouse TIM-4-Ig fusion protein
BE0171-25MG	InVivoMab anti-mouse TIM-4	?	RMT4-53	mouse	TIM-4	rat	IgG2b, κ	Mouse TIM-4-Ig fusion protein
BE0171-50MG	InVivoMab anti-mouse TIM-4	?	RMT4-53	mouse	TIM-4	rat	IgG2b, κ	Mouse TIM-4-Ig fusion protein
BE0172-100MG	InVivoMab anti-mouse MHC Class I (H-2Kb)	?	Y-3	mouse	MHC Class I (H-2Kb)	mouse	IgG2b, κ	Con A stimulated spleen cells from BALB.B mice
BE0172-1MG	InVivoMab anti-mouse MHC Class I (H-2Kb)	?	Y-3	mouse	MHC Class I (H-2Kb)	mouse	IgG2b, κ	Con A stimulated spleen cells from BALB.B mice
BE0172-5MG	InVivoMab anti-mouse MHC Class I (H-2Kb)	?	Y-3	mouse	MHC Class I (H-2Kb)	mouse	IgG2b, κ	Con A stimulated spleen cells from BALB.B mice
BE0172-25MG	InVivoMab anti-mouse MHC Class I (H-2Kb)	?	Y-3	mouse	MHC Class I (H-2Kb)	mouse	IgG2b, κ	Con A stimulated spleen cells from BALB.B mice
BE0172-50MG	InVivoMab anti-mouse MHC Class I (H-2Kb)	?	Y-3	mouse	MHC Class I (H-2Kb)	mouse	IgG2b, κ	Con A stimulated spleen cells from BALB.B mice
BE0173-100MG	InVivoMab anti-mouse IL-17A	?	17F3	mouse	IL-17A	mouse	IgG1, κ	Mouse IL-17A cross-linked to OVA
BE0173-1MG	InVivoMab anti-mouse IL-17A	?	17F3	mouse	IL-17A	mouse	IgG1, κ	Mouse IL-17A cross-linked to OVA
BE0173-5MG	InVivoMab anti-mouse IL-17A	?	17F3	mouse	IL-17A	mouse	IgG1, κ	Mouse IL-17A cross-linked to OVA
BE0173-25MG	InVivoMab anti-mouse IL-17A	?	17F3	mouse	IL-17A	mouse	IgG1, κ	Mouse IL-17A cross-linked to OVA
BE0173-50MG	InVivoMab anti-mouse IL-17A	?	17F3	mouse	IL-17A	mouse	IgG1, κ	Mouse IL-17A cross-linked to OVA
BE0174-100MG	InVivoMab anti-mouse LAG-3	?	C9B7W	mouse	LAG-3	rat	IgG1, κ	Mouse CD223-Ig fusion protein
BE0174-1MG	InVivoMab anti-mouse LAG-3	?	C9B7W	mouse	LAG-3	rat	IgG1, κ	Mouse CD223-Ig fusion protein
BE0174-5MG	InVivoMab anti-mouse LAG-3	?	C9B7W	mouse	LAG-3	rat	IgG1, κ	Mouse CD223-Ig fusion protein
BE0174-25MG	InVivoMab anti-mouse LAG-3	?	C9B7W	mouse	LAG-3	rat	IgG1, κ	Mouse CD223-Ig fusion protein
BE0174-50MG	InVivoMab anti-mouse LAG-3	?	C9B7W	mouse	LAG-3	rat	IgG1, κ	Mouse CD223-Ig fusion protein
BE0175-100MG	InVivoMab anti-mouse CD71 (TfR1)	?	R17 217.1.3/TIB-219	mouse	CD71 (TfR1)	rat?	IgG2a	Mouse erythroleukemia cell line 745.6
BE0175-1MG	InVivoMab anti-mouse CD71 (TfR1)	?	R17 217.1.3/TIB-219	mouse	CD71 (TfR1)	rat?	IgG2a	Mouse erythroleukemia cell line 745.6
BE0175-5MG	InVivoMab anti-mouse CD71 (TfR1)	?	R17 217.1.3/TIB-219	mouse	CD71 (TfR1)	rat?	IgG2a	Mouse erythroleukemia cell line 745.6
BE0175-25MG	InVivoMab anti-mouse CD71 (TfR1)	?	R17 217.1.3/TIB-219	mouse	CD71 (TfR1)	rat?	IgG2a	Mouse erythroleukemia cell line 745.6
BE0175-50MG	InVivoMab anti-mouse CD71 (TfR1)	?	R17 217.1.3/TIB-219	mouse	CD71 (TfR1)	rat?	IgG2a	Mouse erythroleukemia cell line 745.6
BE0176-100MG	InVivoMab anti-mouse Kappa Immunoglobulin Light Chain	?	187.1/HB-58	mouse	Kappa Immunoglobulin Light Chain	rat	IgG1, κ	Mouse IgG2b Isotype control antibody clone MPC-11
BE0176-1MG	InVivoMab anti-mouse Kappa Immunoglobulin Light Chain	?	187.1/HB-58	mouse	Kappa Immunoglobulin Light Chain	rat	IgG1, κ	Mouse IgG2b Isotype control antibody clone MPC-11
BE0176-5MG	InVivoMab anti-mouse Kappa Immunoglobulin Light Chain	?	187.1/HB-58	mouse	Kappa Immunoglobulin Light Chain	rat	IgG1, κ	Mouse IgG2b Isotype control antibody clone MPC-11
BE0176-25MG	InVivoMab anti-mouse Kappa Immunoglobulin Light Chain	?	187.1/HB-58	mouse	Kappa Immunoglobulin Light Chain	rat	IgG1, κ	Mouse IgG2b Isotype control antibody clone MPC-11
BE0176-50MG	InVivoMab anti-mouse Kappa Immunoglobulin Light Chain	?	187.1/HB-58	mouse	Kappa Immunoglobulin Light Chain	rat	IgG1, κ	Mouse IgG2b Isotype control antibody clone MPC-11
BE0178-100MG	InVivoMab anti-mouse MHC class II (I-A)	?	Y-3P	mouse	MHC class II (I-A)	mouse?	IgG2a	BALB/c x C57BL/6 F1 mouse spleen cells
BE0178-1MG	InVivoMab anti-mouse MHC class II (I-A)	?	Y-3P	mouse	MHC class II (I-A)	mouse?	IgG2a	BALB/c x C57BL/6 F1 mouse spleen cells
BE0178-5MG	InVivoMab anti-mouse MHC class II (I-A)	?	Y-3P	mouse	MHC class II (I-A)	mouse?	IgG2a	BALB/c x C57BL/6 F1 mouse spleen cells
BE0178-25MG	InVivoMab anti-mouse MHC class II (I-A)	?	Y-3P	mouse	MHC class II (I-A)	mouse?	IgG2a	BALB/c x C57BL/6 F1 mouse spleen cells
BE0178-50MG	InVivoMab anti-mouse MHC class II (I-A)	?	Y-3P	mouse	MHC class II (I-A)	mouse?	IgG2a	BALB/c x C57BL/6 F1 mouse spleen cells
BE0179-100MG	InVivoMab anti-mouse CD1d (CD1.1)	?	20H2 (HB-323)	mouse	CD1d (CD1.1)	rat	IgG1, κ	CD1.1-transfected rat cell line RBL-CD1.1 followed by CD1.1-transfected human cell line CR1-CD1.1
BE0179-1MG	InVivoMab anti-mouse CD1d (CD1.1)	?	20H2 (HB-323)	mouse	CD1d (CD1.1)	rat	IgG1, κ	CD1.1-transfected rat cell line RBL-CD1.1 followed by CD1.1-transfected human cell line CR1-CD1.1
BE0179-5MG	InVivoMab anti-mouse CD1d (CD1.1)	?	20H2 (HB-323)	mouse	CD1d (CD1.1)	rat	IgG1, κ	CD1.1-transfected rat cell line RBL-CD1.1 followed by CD1.1-transfected human cell line CR1-CD1.1
BE0179-25MG	InVivoMab anti-mouse CD1d (CD1.1)	?	20H2 (HB-323)	mouse	CD1d (CD1.1)	rat	IgG1, κ	CD1.1-transfected rat cell line RBL-CD1.1 followed by CD1.1-transfected human cell line CR1-CD1.1
BE0179-50MG	InVivoMab anti-mouse CD1d (CD1.1)	?	20H2 (HB-323)	mouse	CD1d (CD1.1)	rat	IgG1, κ	CD1.1-transfected rat cell line RBL-CD1.1 followed by CD1.1-transfected human cell line CR1-CD1.1
BE0180-100MG	InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd)	?	34-1-2S	mouse	MHC Class I (H-2Kd, H-2Dd)	mouse	IgG2a, κ	BDF mouse spleen cells
BE0180-1MG	InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd)	?	34-1-2S	mouse	MHC Class I (H-2Kd, H-2Dd)	mouse	IgG2a, κ	BDF mouse spleen cells
BE0180-5MG	InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd)	?	34-1-2S	mouse	MHC Class I (H-2Kd, H-2Dd)	mouse	IgG2a, κ	BDF mouse spleen cells
BE0180-25MG	InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd)	?	34-1-2S	mouse	MHC Class I (H-2Kd, H-2Dd)	mouse	IgG2a, κ	BDF mouse spleen cells
BE0180-50MG	InVivoMab anti-mouse MHC Class I (H-2Kd, H-2Dd)	?	34-1-2S	mouse	MHC Class I (H-2Kd, H-2Dd)	mouse	IgG2a, κ	BDF mouse spleen cells
BE0181-100MG	InVivoMab anti-mouse IL-9	?	9C1	mouse	IL-9	mouse?	IgG2a	Mouse IL-9-OVA complex
BE0181-1MG	InVivoMab anti-mouse IL-9	?	9C1	mouse	IL-9	mouse?	IgG2a	Mouse IL-9-OVA complex
BE0181-5MG	InVivoMab anti-mouse IL-9	?	9C1	mouse	IL-9	mouse?	IgG2a	Mouse IL-9-OVA complex
BE0181-25MG	InVivoMab anti-mouse IL-9	?	9C1	mouse	IL-9	mouse?	IgG2a	Mouse IL-9-OVA complex
BE0181-50MG	InVivoMab anti-mouse IL-9	?	9C1	mouse	IL-9	mouse?	IgG2a	Mouse IL-9-OVA complex
BE0182-100MG	InVivoMab anti-mouse Vβ8 TCR	?	F23.1	mouse	Vβ8 TCR	mouse	IgG2a, κ	BALB.B Mouse lymph node and spleen T cells
BE0182-1MG	InVivoMab anti-mouse Vβ8 TCR	?	F23.1	mouse	Vβ8 TCR	mouse	IgG2a, κ	BALB.B Mouse lymph node and spleen T cells
BE0182-5MG	InVivoMab anti-mouse Vβ8 TCR	?	F23.1	mouse	Vβ8 TCR	mouse	IgG2a, κ	BALB.B Mouse lymph node and spleen T cells
BE0182-25MG	InVivoMab anti-mouse Vβ8 TCR	?	F23.1	mouse	Vβ8 TCR	mouse	IgG2a, κ	BALB.B Mouse lymph node and spleen T cells
BE0182-50MG	InVivoMab anti-mouse Vβ8 TCR	?	F23.1	mouse	Vβ8 TCR	mouse	IgG2a, κ	BALB.B Mouse lymph node and spleen T cells
BE0183-100MG	InVivoMab anti-mouse Ter-119	?	TER-119	mouse	Ter-119	rat	IgG2b, κ	C57BL/6 mouse fetal liver cells
BE0183-1MG	InVivoMab anti-mouse Ter-119	?	TER-119	mouse	Ter-119	rat	IgG2b, κ	C57BL/6 mouse fetal liver cells
BE0183-5MG	InVivoMab anti-mouse Ter-119	?	TER-119	mouse	Ter-119	rat	IgG2b, κ	C57BL/6 mouse fetal liver cells
BE0183-25MG	InVivoMab anti-mouse Ter-119	?	TER-119	mouse	Ter-119	rat	IgG2b, κ	C57BL/6 mouse fetal liver cells
BE0183-50MG	InVivoMab anti-mouse Ter-119	?	TER-119	mouse	Ter-119	rat	IgG2b, κ	C57BL/6 mouse fetal liver cells
BE0185-100MG	InVivoMab anti-human/mouse, rat CCL2 (MCP-1)	?	2H5	mouse/human/rat	CCL2 (MCP-1)	Armenian hamster	IgG, κ	CHO-expressed mouse MCP-1
BE0185-1MG	InVivoMab anti-human/mouse, rat CCL2 (MCP-1)	?	2H5	mouse/human/rat	CCL2 (MCP-1)	Armenian hamster	IgG, κ	CHO-expressed mouse MCP-1
BE0185-5MG	InVivoMab anti-human/mouse, rat CCL2 (MCP-1)	?	2H5	mouse/human/rat	CCL2 (MCP-1)	Armenian hamster	IgG, κ	CHO-expressed mouse MCP-1
BE0185-25MG	InVivoMab anti-human/mouse, rat CCL2 (MCP-1)	?	2H5	mouse/human/rat	CCL2 (MCP-1)	Armenian hamster	IgG, κ	CHO-expressed mouse MCP-1
BE0185-50MG	InVivoMab anti-human/mouse, rat CCL2 (MCP-1)	?	2H5	mouse/human/rat	CCL2 (MCP-1)	Armenian hamster	IgG, κ	CHO-expressed mouse MCP-1
BE0186-100MG	InVivoMab anti-mouse PSGL-1 (CD162)	?	4RA10	mouse	PSGL-1 (CD162)	rat	IgG1, κ	Mouse PSGL-1 human IgG1 fusion protein
BE0186-1MG	InVivoMab anti-mouse PSGL-1 (CD162)	?	4RA10	mouse	PSGL-1 (CD162)	rat	IgG1, κ	Mouse PSGL-1 human IgG1 fusion protein
BE0186-5MG	InVivoMab anti-mouse PSGL-1 (CD162)	?	4RA10	mouse	PSGL-1 (CD162)	rat	IgG1, κ	Mouse PSGL-1 human IgG1 fusion protein
BE0186-25MG	InVivoMab anti-mouse PSGL-1 (CD162)	?	4RA10	mouse	PSGL-1 (CD162)	rat	IgG1, κ	Mouse PSGL-1 human IgG1 fusion protein
BE0186-50MG	InVivoMab anti-mouse PSGL-1 (CD162)	?	4RA10	mouse	PSGL-1 (CD162)	rat	IgG1, κ	Mouse PSGL-1 human IgG1 fusion protein
BE0187-100MG	InVivoMab anti-rat CD80	?	3H5	rat	CD80	mouse	IgG1, κ	HTLV-1-transformed Lewis-S1 rat T cell line
BE0187-1MG	InVivoMab anti-rat CD80	?	3H5	rat	CD80	mouse	IgG1, κ	HTLV-1-transformed Lewis-S1 rat T cell line
BE0187-5MG	InVivoMab anti-rat CD80	?	3H5	rat	CD80	mouse	IgG1, κ	HTLV-1-transformed Lewis-S1 rat T cell line
BE0187-25MG	InVivoMab anti-rat CD80	?	3H5	rat	CD80	mouse	IgG1, κ	HTLV-1-transformed Lewis-S1 rat T cell line
BE0187-50MG	InVivoMab anti-rat CD80	?	3H5	rat	CD80	mouse	IgG1, κ	HTLV-1-transformed Lewis-S1 rat T cell line
BE0188-100MG	InVivoMab anti-human PD-1 (CD279)	?	J116	human	PD-1 (CD279)	mouse	IgG1, κ	?
BE0188-1MG	InVivoMab anti-human PD-1 (CD279)	?	J116	human	PD-1 (CD279)	mouse	IgG1, κ	?
BE0188-5MG	InVivoMab anti-human PD-1 (CD279)	?	J116	human	PD-1 (CD279)	mouse	IgG1, κ	?
BE0188-25MG	InVivoMab anti-human PD-1 (CD279)	?	J116	human	PD-1 (CD279)	mouse	IgG1, κ	?
BE0188-50MG	InVivoMab anti-human PD-1 (CD279)	?	J116	human	PD-1 (CD279)	mouse	IgG1, κ	?
BE0189-100MG	InVivoMab anti-human CD40	?	G28.5	human	CD40	mouse	IgG1, κ	Human tonsillar lymphocytes
BE0189-1MG	InVivoMab anti-human CD40	?	G28.5	human	CD40	mouse	IgG1, κ	Human tonsillar lymphocytes
BE0189-5MG	InVivoMab anti-human CD40	?	G28.5	human	CD40	mouse	IgG1, κ	Human tonsillar lymphocytes
BE0189-25MG	InVivoMab anti-human CD40	?	G28.5	human	CD40	mouse	IgG1, κ	Human tonsillar lymphocytes
BE0189-50MG	InVivoMab anti-human CD40	?	G28.5	human	CD40	mouse	IgG1, κ	Human tonsillar lymphocytes
BE0190-100MG	InVivoMab anti-human CTLA-4 (CD152)	?	BN13	human	CTLA-4 (CD152)	mouse	IgG2a, κ	Human CTLA-4 recombinant protein
BE0190-1MG	InVivoMab anti-human CTLA-4 (CD152)	?	BN13	human	CTLA-4 (CD152)	mouse	IgG2a, κ	Human CTLA-4 recombinant protein
BE0190-5MG	InVivoMab anti-human CTLA-4 (CD152)	?	BN13	human	CTLA-4 (CD152)	mouse	IgG2a, κ	Human CTLA-4 recombinant protein
BE0190-25MG	InVivoMab anti-human CTLA-4 (CD152)	?	BN13	human	CTLA-4 (CD152)	mouse	IgG2a, κ	Human CTLA-4 recombinant protein
BE0190-50MG	InVivoMab anti-human CTLA-4 (CD152)	?	BN13	human	CTLA-4 (CD152)	mouse	IgG2a, κ	Human CTLA-4 recombinant protein
BE0191-100MG	InVivoMab anti-mouse RANKL (CD254)	?	IK22/5	mouse	RANKL (CD254)	rat	IgG2a, κ	NSO-derived recombinant mouse RANKL
BE0191-1MG	InVivoMab anti-mouse RANKL (CD254)	?	IK22/5	mouse	RANKL (CD254)	rat	IgG2a, κ	NSO-derived recombinant mouse RANKL
BE0191-5MG	InVivoMab anti-mouse RANKL (CD254)	?	IK22/5	mouse	RANKL (CD254)	rat	IgG2a, κ	NSO-derived recombinant mouse RANKL
BE0191-25MG	InVivoMab anti-mouse RANKL (CD254)	?	IK22/5	mouse	RANKL (CD254)	rat	IgG2a, κ	NSO-derived recombinant mouse RANKL
BE0191-50MG	InVivoMab anti-mouse RANKL (CD254)	?	IK22/5	mouse	RANKL (CD254)	rat	IgG2a, κ	NSO-derived recombinant mouse RANKL
BE0192-100MG	InVivoMab anti-human CD11a (LFA-1α)	?	R7-1	human	CD11a (LFA-1α)	mouse?	IgG1	?
BE0192-1MG	InVivoMab anti-human CD11a (LFA-1α)	?	R7-1	human	CD11a (LFA-1α)	mouse?	IgG1	?
BE0192-5MG	InVivoMab anti-human CD11a (LFA-1α)	?	R7-1	human	CD11a (LFA-1α)	mouse?	IgG1	?
BE0192-25MG	InVivoMab anti-human CD11a (LFA-1α)	?	R7-1	human	CD11a (LFA-1α)	mouse?	IgG1	?
BE0192-50MG	InVivoMab anti-human CD11a (LFA-1α)	?	R7-1	human	CD11a (LFA-1α)	mouse?	IgG1	?
BE0193-100MG	InVivoMab anti-human PD-1 (CD279)	?	J110	human	PD-1 (CD279)	mouse?	IgG1	?
BE0193-1MG	InVivoMab anti-human PD-1 (CD279)	?	J110	human	PD-1 (CD279)	mouse?	IgG1	?
BE0193-5MG	InVivoMab anti-human PD-1 (CD279)	?	J110	human	PD-1 (CD279)	mouse?	IgG1	?
BE0193-25MG	InVivoMab anti-human PD-1 (CD279)	?	J110	human	PD-1 (CD279)	mouse?	IgG1	?
BE0193-50MG	InVivoMab anti-human PD-1 (CD279)	?	J110	human	PD-1 (CD279)	mouse?	IgG1	?
BE0194-100MG	InVivoMab anti-Phosphotyrosine	?	4G10	n/a	Phosphotyrosine	mouse?	IgG2b	Phosphotyramine-KLH
BE0194-1MG	InVivoMab anti-Phosphotyrosine	?	4G10	n/a	Phosphotyrosine	mouse?	IgG2b	Phosphotyramine-KLH
BE0194-5MG	InVivoMab anti-Phosphotyrosine	?	4G10	n/a	Phosphotyrosine	mouse?	IgG2b	Phosphotyramine-KLH
BE0194-25MG	InVivoMab anti-Phosphotyrosine	?	4G10	n/a	Phosphotyrosine	mouse?	IgG2b	Phosphotyramine-KLH
BE0194-50MG	InVivoMab anti-Phosphotyrosine	?	4G10	n/a	Phosphotyrosine	mouse?	IgG2b	Phosphotyramine-KLH
BE0196-100MG	InVivoMab anti-mouse BTLA (CD272)	?	PJ196	mouse	BTLA (CD272)	mouse?	IgG1	?
BE0196-1MG	InVivoMab anti-mouse BTLA (CD272)	?	PJ196	mouse	BTLA (CD272)	mouse?	IgG1	?
BE0196-5MG	InVivoMab anti-mouse BTLA (CD272)	?	PJ196	mouse	BTLA (CD272)	mouse?	IgG1	?
BE0196-25MG	InVivoMab anti-mouse BTLA (CD272)	?	PJ196	mouse	BTLA (CD272)	mouse?	IgG1	?
BE0196-50MG	InVivoMab anti-mouse BTLA (CD272)	?	PJ196	mouse	BTLA (CD272)	mouse?	IgG1	?
BE0198-100MG	InVivoMab anti-mouse/human IL-5	?	TRFK5	mouse/human	IL-5	rat	IgG1, κ	Mouse partially-purified T cell clone supernatant
BE0198-1MG	InVivoMab anti-mouse/human IL-5	?	TRFK5	mouse/human	IL-5	rat	IgG1, κ	Mouse partially-purified T cell clone supernatant
BE0198-5MG	InVivoMab anti-mouse/human IL-5	?	TRFK5	mouse/human	IL-5	rat	IgG1, κ	Mouse partially-purified T cell clone supernatant
BE0198-25MG	InVivoMab anti-mouse/human IL-5	?	TRFK5	mouse/human	IL-5	rat	IgG1, κ	Mouse partially-purified T cell clone supernatant
BE0198-50MG	InVivoMab anti-mouse/human IL-5	?	TRFK5	mouse/human	IL-5	rat	IgG1, κ	Mouse partially-purified T cell clone supernatant
BE0199-100MG	InVivoMab anti-mouse IL-4	?	BVD6-24G2	mouse	IL-4	rat	IgG1, κ	Recombinant mouse IL-4
BE0199-1MG	InVivoMab anti-mouse IL-4	?	BVD6-24G2	mouse	IL-4	rat	IgG1, κ	Recombinant mouse IL-4
BE0199-5MG	InVivoMab anti-mouse IL-4	?	BVD6-24G2	mouse	IL-4	rat	IgG1, κ	Recombinant mouse IL-4
BE0199-25MG	InVivoMab anti-mouse IL-4	?	BVD6-24G2	mouse	IL-4	rat	IgG1, κ	Recombinant mouse IL-4
BE0199-50MG	InVivoMab anti-mouse IL-4	?	BVD6-24G2	mouse	IL-4	rat	IgG1, κ	Recombinant mouse IL-4
BE0200-100MG	InVivoMab anti-mouse Pan-endothelial Cell Antigen (MECA-32)	?	MECA-32	mouse	Pan-endothelial Cell Antigen (MECA-32)	rat	IgG2a, κ	Mouse lymph node stromal cells
BE0200-1MG	InVivoMab anti-mouse Pan-endothelial Cell Antigen (MECA-32)	?	MECA-32	mouse	Pan-endothelial Cell Antigen (MECA-32)	rat	IgG2a, κ	Mouse lymph node stromal cells
BE0200-5MG	InVivoMab anti-mouse Pan-endothelial Cell Antigen (MECA-32)	?	MECA-32	mouse	Pan-endothelial Cell Antigen (MECA-32)	rat	IgG2a, κ	Mouse lymph node stromal cells
BE0200-25MG	InVivoMab anti-mouse Pan-endothelial Cell Antigen (MECA-32)	?	MECA-32	mouse	Pan-endothelial Cell Antigen (MECA-32)	rat	IgG2a, κ	Mouse lymph node stromal cells
BE0200-50MG	InVivoMab anti-mouse Pan-endothelial Cell Antigen (MECA-32)	?	MECA-32	mouse	Pan-endothelial Cell Antigen (MECA-32)	rat	IgG2a, κ	Mouse lymph node stromal cells
BE0201-100MG	InVivoMab anti-mouse/human KLRG-1	?	2F1	mouse/human	KLRG-1	Syrian hamster	IgG	IL-2 activated C57BL/6 mouse NK cells
BE0201-1MG	InVivoMab anti-mouse/human KLRG-1	?	2F1	mouse/human	KLRG-1	Syrian hamster	IgG	IL-2 activated C57BL/6 mouse NK cells
BE0201-5MG	InVivoMab anti-mouse/human KLRG-1	?	2F1	mouse/human	KLRG-1	Syrian hamster	IgG	IL-2 activated C57BL/6 mouse NK cells
BE0201-25MG	InVivoMab anti-mouse/human KLRG-1	?	2F1	mouse/human	KLRG-1	Syrian hamster	IgG	IL-2 activated C57BL/6 mouse NK cells
BE0201-50MG	InVivoMab anti-mouse/human KLRG-1	?	2F1	mouse/human	KLRG-1	Syrian hamster	IgG	IL-2 activated C57BL/6 mouse NK cells
BE0202-100MG	InVivoMab anti-mouse Siglec-H	?	440c	mouse	Siglec-H	rat?	IgG2b	Purified bone marrow-derived IPCs
BE0202-1MG	InVivoMab anti-mouse Siglec-H	?	440c	mouse	Siglec-H	rat?	IgG2b	Purified bone marrow-derived IPCs
BE0202-5MG	InVivoMab anti-mouse Siglec-H	?	440c	mouse	Siglec-H	rat?	IgG2b	Purified bone marrow-derived IPCs
BE0202-25MG	InVivoMab anti-mouse Siglec-H	?	440c	mouse	Siglec-H	rat?	IgG2b	Purified bone marrow-derived IPCs
BE0202-50MG	InVivoMab anti-mouse Siglec-H	?	440c	mouse	Siglec-H	rat?	IgG2b	Purified bone marrow-derived IPCs
BE0203-100MG	InVivoMab anti-mouse Ly6C	?	MONTS-1	mouse	Ly6C	rat?	IgG2a	?
BE0203-1MG	InVivoMab anti-mouse Ly6C	?	MONTS-1	mouse	Ly6C	rat?	IgG2a	?
BE0203-5MG	InVivoMab anti-mouse Ly6C	?	MONTS-1	mouse	Ly6C	rat?	IgG2a	?
BE0203-25MG	InVivoMab anti-mouse Ly6C	?	MONTS-1	mouse	Ly6C	rat?	IgG2a	?
BE0203-50MG	InVivoMab anti-mouse Ly6C	?	MONTS-1	mouse	Ly6C	rat?	IgG2a	?
BE0204-100MG	InVivoMab anti-mouse CSF1	?	5A1	mouse	CSF1	rat	IgG1, κ	Purified mouse CSF-1
BE0204-1MG	InVivoMab anti-mouse CSF1	?	5A1	mouse	CSF1	rat	IgG1, κ	Purified mouse CSF-1
BE0204-5MG	InVivoMab anti-mouse CSF1	?	5A1	mouse	CSF1	rat	IgG1, κ	Purified mouse CSF-1
BE0204-25MG	InVivoMab anti-mouse CSF1	?	5A1	mouse	CSF1	rat	IgG1, κ	Purified mouse CSF-1
BE0204-50MG	InVivoMab anti-mouse CSF1	?	5A1	mouse	CSF1	rat	IgG1, κ	Purified mouse CSF-1
BE0206-100MG	InVivoMab anti-mouse F4/80	?	CI:A3-1	mouse	F4/80	rat?	IgG2b	C57BL/6 mouse thioglycollate stimulated peritoneal macrophages
BE0206-1MG	InVivoMab anti-mouse F4/80	?	CI:A3-1	mouse	F4/80	rat?	IgG2b	C57BL/6 mouse thioglycollate stimulated peritoneal macrophages
BE0206-5MG	InVivoMab anti-mouse F4/80	?	CI:A3-1	mouse	F4/80	rat?	IgG2b	C57BL/6 mouse thioglycollate stimulated peritoneal macrophages
BE0206-25MG	InVivoMab anti-mouse F4/80	?	CI:A3-1	mouse	F4/80	rat?	IgG2b	C57BL/6 mouse thioglycollate stimulated peritoneal macrophages
BE0206-50MG	InVivoMab anti-mouse F4/80	?	CI:A3-1	mouse	F4/80	rat?	IgG2b	C57BL/6 mouse thioglycollate stimulated peritoneal macrophages
BE0207-100MG	InVivoMab anti-mouse MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	?	25-D1.16	mouse	MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	mouse	IgG1, κ	SIINFEKL pulsed RMA-S cells
BE0207-1MG	InVivoMab anti-mouse MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	?	25-D1.16	mouse	MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	mouse	IgG1, κ	SIINFEKL pulsed RMA-S cells
BE0207-5MG	InVivoMab anti-mouse MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	?	25-D1.16	mouse	MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	mouse	IgG1, κ	SIINFEKL pulsed RMA-S cells
BE0207-25MG	InVivoMab anti-mouse MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	?	25-D1.16	mouse	MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	mouse	IgG1, κ	SIINFEKL pulsed RMA-S cells
BE0207-50MG	InVivoMab anti-mouse MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	?	25-D1.16	mouse	MHC Class I (H-2Kb) bound to SIINFEKL peptide (OVA residues 257-264)	mouse	IgG1, κ	SIINFEKL pulsed RMA-S cells
BE0209-100MG	InVivoMab anti-mouse CD73	?	TY/23	mouse	CD73	rat	IgG2a, κ	BALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
BE0209-1MG	InVivoMab anti-mouse CD73	?	TY/23	mouse	CD73	rat	IgG2a, κ	BALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
BE0209-5MG	InVivoMab anti-mouse CD73	?	TY/23	mouse	CD73	rat	IgG2a, κ	BALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
BE0209-25MG	InVivoMab anti-mouse CD73	?	TY/23	mouse	CD73	rat	IgG2a, κ	BALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
BE0209-50MG	InVivoMab anti-mouse CD73	?	TY/23	mouse	CD73	rat	IgG2a, κ	BALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
BE0210-100MG	InVivoMab anti-mouse BTLA (CD272)	?	8F4	mouse	BTLA (CD272)	mouse	IgG1, κ	C57BL/6 mouse BTLA Ig domain
BE0210-1MG	InVivoMab anti-mouse BTLA (CD272)	?	8F4	mouse	BTLA (CD272)	mouse	IgG1, κ	C57BL/6 mouse BTLA Ig domain
BE0210-5MG	InVivoMab anti-mouse BTLA (CD272)	?	8F4	mouse	BTLA (CD272)	mouse	IgG1, κ	C57BL/6 mouse BTLA Ig domain
BE0210-25MG	InVivoMab anti-mouse BTLA (CD272)	?	8F4	mouse	BTLA (CD272)	mouse	IgG1, κ	C57BL/6 mouse BTLA Ig domain
BE0210-50MG	InVivoMab anti-mouse BTLA (CD272)	?	8F4	mouse	BTLA (CD272)	mouse	IgG1, κ	C57BL/6 mouse BTLA Ig domain
BE0211-100MG	InVivoMab anti-human CD1a	?	OKT-6	human	CD1a	mouse?	IgG1	Human acute lymphoblastic leukaemia cells
BE0211-1MG	InVivoMab anti-human CD1a	?	OKT-6	human	CD1a	mouse?	IgG1	Human acute lymphoblastic leukaemia cells
BE0211-5MG	InVivoMab anti-human CD1a	?	OKT-6	human	CD1a	mouse?	IgG1	Human acute lymphoblastic leukaemia cells
BE0211-25MG	InVivoMab anti-human CD1a	?	OKT-6	human	CD1a	mouse?	IgG1	Human acute lymphoblastic leukaemia cells
BE0211-50MG	InVivoMab anti-human CD1a	?	OKT-6	human	CD1a	mouse?	IgG1	Human acute lymphoblastic leukaemia cells
BE0213-100MG	InVivoMab anti-mouse CSF1R (CD115)	?	AFS98	mouse	CSF1R (CD115)	rat	IgG2a, κ	?
BE0213-1MG	InVivoMab anti-mouse CSF1R (CD115)	?	AFS98	mouse	CSF1R (CD115)	rat	IgG2a, κ	?
BE0213-5MG	InVivoMab anti-mouse CSF1R (CD115)	?	AFS98	mouse	CSF1R (CD115)	rat	IgG2a, κ	?
BE0213-25MG	InVivoMab anti-mouse CSF1R (CD115)	?	AFS98	mouse	CSF1R (CD115)	rat	IgG2a, κ	?
BE0213-50MG	InVivoMab anti-mouse CSF1R (CD115)	?	AFS98	mouse	CSF1R (CD115)	rat	IgG2a, κ	?
BE0214-100MG	InVivoMab anti-mouse Thy1.1 (CD90.1)	?	19E12	mouse	Thy1.1 (CD90.1)	mouse?	IgG2a	AKR mouse SL3 leukemia cells
BE0214-1MG	InVivoMab anti-mouse Thy1.1 (CD90.1)	?	19E12	mouse	Thy1.1 (CD90.1)	mouse?	IgG2a	AKR mouse SL3 leukemia cells
BE0214-5MG	InVivoMab anti-mouse Thy1.1 (CD90.1)	?	19E12	mouse	Thy1.1 (CD90.1)	mouse?	IgG2a	AKR mouse SL3 leukemia cells
BE0214-25MG	InVivoMab anti-mouse Thy1.1 (CD90.1)	?	19E12	mouse	Thy1.1 (CD90.1)	mouse?	IgG2a	AKR mouse SL3 leukemia cells
BE0214-50MG	InVivoMab anti-mouse Thy1.1 (CD90.1)	?	19E12	mouse	Thy1.1 (CD90.1)	mouse?	IgG2a	AKR mouse SL3 leukemia cells
BE0216-100MG	InVivoMab anti-human YB-1	?	21A3	human	YB-1	mouse?	IgG1	Recombinant human YB-1
BE0216-1MG	InVivoMab anti-human YB-1	?	21A3	human	YB-1	mouse?	IgG1	Recombinant human YB-1
BE0216-5MG	InVivoMab anti-human YB-1	?	21A3	human	YB-1	mouse?	IgG1	Recombinant human YB-1
BE0216-25MG	InVivoMab anti-human YB-1	?	21A3	human	YB-1	mouse?	IgG1	Recombinant human YB-1
BE0216-50MG	InVivoMab anti-human YB-1	?	21A3	human	YB-1	mouse?	IgG1	Recombinant human YB-1
BE0218-100MG	InVivoMab anti-mouse Galectin-9	?	RG9-1	mouse	Galectin-9	rat	IgG2b, κ	Recombinant mouse galectin-9
BE0218-1MG	InVivoMab anti-mouse Galectin-9	?	RG9-1	mouse	Galectin-9	rat	IgG2b, κ	Recombinant mouse galectin-9
BE0218-5MG	InVivoMab anti-mouse Galectin-9	?	RG9-1	mouse	Galectin-9	rat	IgG2b, κ	Recombinant mouse galectin-9
BE0218-25MG	InVivoMab anti-mouse Galectin-9	?	RG9-1	mouse	Galectin-9	rat	IgG2b, κ	Recombinant mouse galectin-9
BE0218-50MG	InVivoMab anti-mouse Galectin-9	?	RG9-1	mouse	Galectin-9	rat	IgG2b, κ	Recombinant mouse galectin-9
BE0220-100MG	InVivoMab anti-mouse CD209b (SIGN-R1)	?	22D1	mouse	CD209b (SIGN-R1)	Armenian hamster	IgG, κ	C-terminal? peptide of mouse SIGN-R1
BE0220-1MG	InVivoMab anti-mouse CD209b (SIGN-R1)	?	22D1	mouse	CD209b (SIGN-R1)	Armenian hamster	IgG, κ	C-terminal? peptide of mouse SIGN-R1
BE0220-5MG	InVivoMab anti-mouse CD209b (SIGN-R1)	?	22D1	mouse	CD209b (SIGN-R1)	Armenian hamster	IgG, κ	C-terminal? peptide of mouse SIGN-R1
BE0220-25MG	InVivoMab anti-mouse CD209b (SIGN-R1)	?	22D1	mouse	CD209b (SIGN-R1)	Armenian hamster	IgG, κ	C-terminal? peptide of mouse SIGN-R1
BE0220-50MG	InVivoMab anti-mouse CD209b (SIGN-R1)	?	22D1	mouse	CD209b (SIGN-R1)	Armenian hamster	IgG, κ	C-terminal? peptide of mouse SIGN-R1
BE0222-100MG	InVivoMab anti-rat FcRn heavy chain heterodimers	?	1G3	rat	FcRn heavy chain heterodimers	mouse?	IgG1	Purified soluble FcRn
BE0222-1MG	InVivoMab anti-rat FcRn heavy chain heterodimers	?	1G3	rat	FcRn heavy chain heterodimers	mouse?	IgG1	Purified soluble FcRn
BE0222-5MG	InVivoMab anti-rat FcRn heavy chain heterodimers	?	1G3	rat	FcRn heavy chain heterodimers	mouse?	IgG1	Purified soluble FcRn
BE0222-25MG	InVivoMab anti-rat FcRn heavy chain heterodimers	?	1G3	rat	FcRn heavy chain heterodimers	mouse?	IgG1	Purified soluble FcRn
BE0222-50MG	InVivoMab anti-rat FcRn heavy chain heterodimers	?	1G3	rat	FcRn heavy chain heterodimers	mouse?	IgG1	Purified soluble FcRn
BE0223-100MG	InVivoMab anti-mouse CD8β (Lyt 3.2)	?	53-5.8	mouse	CD8β (Lyt 3.2)	rat	IgG1, κ	Mouse thymus or spleen
BE0223-1MG	InVivoMab anti-mouse CD8β (Lyt 3.2)	?	53-5.8	mouse	CD8β (Lyt 3.2)	rat	IgG1, κ	Mouse thymus or spleen
BE0223-5MG	InVivoMab anti-mouse CD8β (Lyt 3.2)	?	53-5.8	mouse	CD8β (Lyt 3.2)	rat	IgG1, κ	Mouse thymus or spleen
BE0223-25MG	InVivoMab anti-mouse CD8β (Lyt 3.2)	?	53-5.8	mouse	CD8β (Lyt 3.2)	rat	IgG1, κ	Mouse thymus or spleen
BE0223-50MG	InVivoMab anti-mouse CD8β (Lyt 3.2)	?	53-5.8	mouse	CD8β (Lyt 3.2)	rat	IgG1, κ	Mouse thymus or spleen
BE0224-100MG	InVivoMab anti-human CD32 (FcγRIIA)	?	IV.3	human	CD32 (FcγRIIA)	mouse?	IgG2b	Human K562 leukemia cell line
BE0224-1MG	InVivoMab anti-human CD32 (FcγRIIA)	?	IV.3	human	CD32 (FcγRIIA)	mouse?	IgG2b	Human K562 leukemia cell line
BE0224-5MG	InVivoMab anti-human CD32 (FcγRIIA)	?	IV.3	human	CD32 (FcγRIIA)	mouse?	IgG2b	Human K562 leukemia cell line
BE0224-25MG	InVivoMab anti-human CD32 (FcγRIIA)	?	IV.3	human	CD32 (FcγRIIA)	mouse?	IgG2b	Human K562 leukemia cell line
BE0224-50MG	InVivoMab anti-human CD32 (FcγRIIA)	?	IV.3	human	CD32 (FcγRIIA)	mouse?	IgG2b	Human K562 leukemia cell line
BE0225-100MG	InVivoMab anti-mouse TIM-4	?	RMT4-54	mouse	TIM-4	rat?	IgG2a	Mouse TIM-4-Ig fusion protein
BE0225-1MG	InVivoMab anti-mouse TIM-4	?	RMT4-54	mouse	TIM-4	rat?	IgG2a	Mouse TIM-4-Ig fusion protein
BE0225-5MG	InVivoMab anti-mouse TIM-4	?	RMT4-54	mouse	TIM-4	rat?	IgG2a	Mouse TIM-4-Ig fusion protein
BE0225-25MG	InVivoMab anti-mouse TIM-4	?	RMT4-54	mouse	TIM-4	rat?	IgG2a	Mouse TIM-4-Ig fusion protein
BE0225-50MG	InVivoMab anti-mouse TIM-4	?	RMT4-54	mouse	TIM-4	rat?	IgG2a	Mouse TIM-4-Ig fusion protein
BE0228-100MG	InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)	?	16-1-2N (HB14)	mouse	MHC Class I (H-2Kk, H-2Dk)	mouse?	IgG2a	C3H mouse spleen cells
BE0228-1MG	InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)	?	16-1-2N (HB14)	mouse	MHC Class I (H-2Kk, H-2Dk)	mouse?	IgG2a	C3H mouse spleen cells
BE0228-5MG	InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)	?	16-1-2N (HB14)	mouse	MHC Class I (H-2Kk, H-2Dk)	mouse?	IgG2a	C3H mouse spleen cells
BE0228-25MG	InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)	?	16-1-2N (HB14)	mouse	MHC Class I (H-2Kk, H-2Dk)	mouse?	IgG2a	C3H mouse spleen cells
BE0228-50MG	InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)	?	16-1-2N (HB14)	mouse	MHC Class I (H-2Kk, H-2Dk)	mouse?	IgG2a	C3H mouse spleen cells

濃度：2-10 mg/m

儲存與安全

儲存:

4℃

關(guān)于我們

Wolcavi Biotech致力于干細胞免疫治療、分子生物學(xué) 、免疫學(xué)、體外診斷等相關(guān)領(lǐng)域的實(shí)驗需求產(chǎn)品開(kāi)發(fā)和銷(xiāo)售。主要產(chǎn)品有抗原抗體|無(wú)血清培養基|細胞培養耗材并代理銷(xiāo)售Abcam、Invitrogen(Gibco)、Roche、Sigma、R&D、Meridian等二十多家國外知名品牌。

聯(lián)系我們

北京市通州區金橋科技園景盛南二街12號納特園區
Phone: +86 010 8646 3560
Email: info@wolcavi.com

新聞

標簽

?
?
?
?
?

?
010-5944 6861

国产三级A三级三级,综合高清免费无码,亚洲一级av不卡毛片无码,亚洲在线一区国产,亚洲国产欧美在线,色一情一乱一伦一区二区三欧美

invivo Mab anti-mouse CTLA-4 (CD152)